Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery
Advanced Science · 2025-08 · 12 (30)
DOI: 10.1002/advs.202503138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 19.06.2025. Verfasst von Qingquan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, P. R. China. Hauptthemen laut MEDLINE: Machine Learning, Nanoparticles, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
In recent years, nanomedicine has emerged as a promising approach to deliver therapeutic agents directly to tumors. However, despite its potential, cancer nanomedicine encounters significant challenges. The synthesis of nanomedicines involves numerous parameters, and the complexity of nano–bio interactions in vivo presents further difficulties. Therefore, innovative approaches are needed to optimize nanoparticle (NP) design and functionality, enhancing their delivery efficiency and therapeutic outcomes. Recent advancements in Machine Learning (ML) and computational methods have shown great promise for precision cancer drug delivery. This review summarizes the potential use of ML across all stages of NP drug delivery systems, along with a discussion of ongoing challenges and future directions. The authors first examine the synthesis and formulation of NPs, highlighting how ML can accelerate the process by searching for optimal synthesis parameters. Next, they delve into nano–bio interactions in drug delivery, including NP–protein interactions, blood circulation, NP extravasation into the tumor microenvironment (TME), tumor penetration and distribution, as well as cellular internalization. Through this comprehensive overview, the authors aim to highlight the transformative potential of ML in overcoming current challenges, assisting nanoscientists in the rational design of NPs, and advancing precision cancer nanomedicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, P. R. China.
- Department of Chemical and Biomolecular Engineering, National University of Singapore, 4 Engineering Drive 4, Singapore, 117585, Singapore.
ORCID-Profile: Qingquan Wang, Yujian Liu, Chenchen Li, Bin Xu, Bin Liu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Program of Guangzhou, China
- Singapore Ministry of Education Research Centre of Excellence through the Institute for Functional Intelligent Materials
- National Key Research and Development Program of China
Zitieren
APA
Wang, Q., Liu, Y., Li, C., Xu, B., Xu, S., & Liu, B. (2025). Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery. Advanced Science, 12(30). https://doi.org/10.1002/advs.202503138
Vancouver
Wang Q, Liu Y, Li C, Xu B, Xu S, Liu B. Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery. Advanced Science. 2025;12(30). doi:10.1002/advs.202503138
BibTeX
@article{Wang2025,
author = {Wang, Qingquan and Liu, Yujian and Li, Chenchen and Xu, Bin and Xu, Shidang and Liu, Bin},
title = {Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {30},
doi = {10.1002/advs.202503138}
}
EUVIMED